The role of major histocompatibility complex molecules in luteal function

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Cannon, Matthew J ^a   Pate, Joy L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; LMP10 PROTEIN; LMP2 PROTEIN; LMP7 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME; UNCLASSIFIED DRUG; HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CORPUS LUTEUM FUNCTION; CYTOKINE RELEASE; CYTOLYSIS; FEMALE; HUMAN; IMMUNOSTIMULATION; LUTEINIZATION; LUTEOLYSIS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMISTRY; CORPUS LUTEUM; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNITY; CORPUS LUTEUM; FEMALE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES;

EID: 4344616018     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-93     Document Type: Review

References (58)

1. Benyo DF, Haibel GK, Laufman HB, Pate JL: Expression of major histocompatibility complex antigens on the bovine corpus luteum during the estrous cycle, luteolysis, and early pregnancy. Biol Reprod 1991, 45:229-23.
2. Kenny N, Herman JR, Barisas BG, Roess DA: Flow cytometric analysis of class I and II MHC antigens on ovine luteal cell types. In: Signaling mechanisms and gene expression in the ovary (Edited by: Gibori G). New York, Springer-Verlag 1991, 467-472.
3. Bukovský A, Caudle MR, Keenan JA, Wimalasena J, Upadhyaya NB, Van Meter SE: Is corpus luteum regression an immune-mediated event? Localization of immune system components and luteinizing hormone receptor in human corpora lutea. Biol Reprod 1995, 53:1373-1384.
4. Lawler DF, Hopkins J, Watson DE: Immune cell populations in the equine corpus luteum throughout the oestrous cycle and early pregnancy: an immunohistochemical and flow cytometric study. J Reprod Fertil 1999, 117:281-290.
5. Penny LA, Armstrong D, Bramley TA, Webb R, Collins RA, Watson ED: Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. J Reprod Fertil 1999, 115:87-96.
6. Lehmann I, Brylla E, Sittig D, Spanel-Borowski K, Aust G: Microvascular endothelial cells differ in their basal and tumour necrosis factor-α-regulated expression of adhesion molecules and cytokines. J Vasc Res 2000, 37:408-416.
7. Khoury EL, Marshall LA: Luteinization of human granulosa cells in vivo is associated with expression of MHC class II antigens. Cell Tissue Res 1990, 262:217-224.
8. + cells in the ovary of immature, young laying and old laying hens Gallus domesticus. J Reprod Fertil 1999, 116:385-389.
9. Barua A, Michiue H, Yoshimura Y: Changes in the localization of MHC class II positive cells in hen ovarian follicles during the processes of follicular growth, postovulatory regression and atresia. Reproduction 2001, 121:953-957.
10. Petroff M, Coggeshall KM, Jones LS, Pate JL: Bovine luteal cells elicit major histocompatibility complex class II-dependent T-cell proliferation. Biol Reprod 1997, 57:887-893.
11. Altman A, Mustelin T, Coggeshall KM: T lymphocyte activation: a biological model of signal transduction. Crit Rev Immunol 1990, 10:347-391.
12. Rock KL, Goldberg AL: Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999, 17:739-779.
13. Tanahashi N, Tsurumi C, Tamura T, Tanaka K: Molecular structure of 20S and 26S proteasomes. Enzyme Protein 1993, 47:241-251.
14. Akiyama K, Kagawa S, Tamura T, Shimbara N, Takashina M, Kristenson P, Hendil KB, Tanaka K, Ichihara A: Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Lett 1994, 343:85-88.
15. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U, Von Boehmer H: MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994, 265:1234-1237.
16. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S: Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994, 1:533-541.
17. Nandi D, Jiang H, Monaco JJ: Identification of MECL-1 (LMP10) as the third IFN-?-inducible proteasome subunit. J Immunol 1996, 156:2361-2364.
18. York IA, Goldberg AL, Mo XY, Rock KL: Proteolysis and class I major histocompatibility complex antigen processing. Immunol Rev 1999, 172:49-66.
19. Glynne R, Powis SH, Beck S, Kelly A, Kerr LA, Trowsdale J: A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991, 353:357-360.
20. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J: Second proteasome-related gene in the human MHC class II region. Nature 1991, 353:667-668.
21. Martinez CK, Monaco JJ: Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 1991, 353:664-667.
22. Akiyama K, Yokota K, Kagawa S, Shimbara N, Tamura T, Akioka H, Nothwang HG, Noda C, Tanaka K, Ichihara A: cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y. Science 1994, 265:1231-1234.
23. Hisamatsu H, Shimbara N, Saito Y, Kristenson P, Hendil KB, Fujiwara T, Takahashi EI, Tanahashi N, Tamura T, Ichihara A, Tanaka K: Newly identified pair of proteasomal subunits regulated reciprocally by interferon-gamma. J Exp Med 1996, 183:1807-1816.
24. Driscoll J, Brown MG, Finley D, Monaco JJ: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993, 365:262-264.
25. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski UH, Kloetzel PM: Inteferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 1994, 179:901-909.
26. Stohwasser R, Standera S, Peters I, Kloetzel PM, Groettrup M: Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: Reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits. Eur J Immunol 1997, 27:1182-1187.
27. Weetman AP: Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003, 148:1-9.
28. Vives-Pi M, Vargas F, James RF, Trowsdale J, Costa M, Sospedra M, Somoza N, Obiols G, Tampe R, Pujol-Borrell R: Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity. Tissue antigens 1997, 50:153-163.
29. Martin A, Barbesino G, Davies TF: T-cell receptors and autoimmune thyroid disease - signposts for T-cell-antigen driven diseases. Int Rev Immunol 1999, 18:111-140.
30. Cannon MJ, Pate JL: Expression and Regulation of Interferon γ-Inducible Proteasomal Subunits LMP7 and LMP10 in the Bovine Corpus Luteum. Biol Reprod 2003, 68:1447-1454.
31. Sant AJ: Endogenous antigen presentation by MHC class II molecules. Immunol Res 1994, 13:235-267.
32. Roche PA, Cresswell P: Invariant chain association with HLA-DR molecule inhibits immunogenic peptide binding. Nature 1990, 345:615-618.
33. Bakke O, Dobberstein B: MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990, 63:707-716.
34. Lotteau V, Teyton L, Péléraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Peterson PA: Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990, 348:600-605.
35. Maric MA, Taylor MD, Blum JS: Endosomal aspartic proteinases are required for invariant chain processing. Proc Natl Acad Sci USA 1994, 91:2171-2175.
36. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA: Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996, 4:357-66.
37. Sanderson F, Kleijmeer MJ, Kelly A, Verwoerd D, Tulp A, Neefjes JJ, Geuze HJ, Trowsdale J: Accumulation of HLA-DM, a regulator of antigen presentation in MHC class II compartments. Science 1994, 266:1566-1569.
38. Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, Monaco JJ, Mellins E: An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994, 368:551-554.
39. Fling SP, Arp B, Pious D: HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994, 368:554-558.
40. Karlsson L, Péléraux A, Lindstedt R, Liljedahl M, Peterson PA: Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 1994, 266:1569-1573.
41. 2a-induced regression. Biol Reprod 2000, 62(suppl 1):144.
42. Roby KF, Terranova PF: Localization of tumor necrosis factor (TNF) in the rat and bovine ovary using immunocytochemistry and cell blot: evidence for granulosal production. In: Growth factors and the Ovary (Edited by: Hirshfield AN). New York, Plenum Press 1989, 273-278.
43. Bagavandoss P, Wiggins RC, Kunkel SC, Remick DG, Keyes PL: Tumor necrosis factor production and accumulation of inflammatory cells in the corpus luteum of pseudopregnancy and pregnancy in rabbits. Biol Reprod 1990, 42:367-376.
44. Ji I, Slaughter RG, Ellis JA, Ji TH, Murdoch WJ: Analyses of ovine corpora lutea for tumor necrosis factor mRNA and bioactivity during prostaglandin-induced luteolysis. Mol Cell Endocrinol 1991, 81:77-80.
45. Shaw DW, Britt JH: Concentrations of tumor necrosis factor alpha and progesterone within the bovine corpus luteum sampled by continuous-flow microdialysis during luteolysis in vivo. Biol Reprod 1995, 53:847-854.
46. Petroff MG, Petroff BK, Pate JL: Expression of cytokine messenger ribonucleic acids in the bovine corpus luteum. Endocrinology 1999, 140:1018-21.
47. Fairchild DL, Pate JL: Interferon-γ induction of major histocompatibility complex antigens on cultured bovine luteal cells. Biol Reprod 1989, 40:453-457.
48. Benyo DL, Pate JL: Tumor necrosis factor-α alters bovine luteal cell synthetic capacity and viability. Endocrinology 1992, 130:854-860.
49. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM: B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991, 88:6575-6579.
50. Chen C, Nabavi N: In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994, 1:147-154.
51. Lechler R, Chai J-G, Marelli-Berg F, Lombardi G: The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology 2001, 103:262-269.
52. Freeman GJ, Boriello F, Hodes RJ, Reiser H, Gribben JG, Ng JW, Kim J, Goldberg JM, Hathcock K, Laszlo G, Lombard LA, Wang S, Gray GS, Nadler LM, Sharpe AH: Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993, 178:2185-2192.
53. Guerder S, Picarella DE, Linsley PS, Flavell RA: Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 1994, 91:5138-5142.
54. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Ann Rev Immunol 1996, 14:233-258.
55. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindstein T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 1995, 3:87-98.
56. Linsley PS, Brady W, Grosmarie L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991, 173:721-730.
57. Flavell RA, Hafler DA: Autoimmunity. What is the turning point? Curr Opin Immunol 1999, 11:635-637.
58. 2a-induced luteal regression. Biol Reprod 2001, 64(suppl 1):287.